These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 20236070)

  • 1. Nitric oxide and pancreatic cancer pathogenesis, prevention, and treatment.
    Wang L; Xie K
    Curr Pharm Des; 2010; 16(4):421-7. PubMed ID: 20236070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting nitric oxide for tumor therapy.
    Contestabile A
    Curr Pharm Des; 2010; 16(4):378-80. PubMed ID: 20236066
    [No Abstract]   [Full Text] [Related]  

  • 3. Nitric oxide and cancer therapy: the emperor has NO clothes.
    Hickok JR; Thomas DD
    Curr Pharm Des; 2010; 16(4):381-91. PubMed ID: 20236067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide in cancer therapeutics: interaction with cytotoxic chemotherapy.
    Hirst D; Robson T
    Curr Pharm Des; 2010; 16(4):411-20. PubMed ID: 20236069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-induced expression of the cellular adhesion molecule L1CAM confers anti-apoptotic protection and chemoresistance in pancreatic ductal adenocarcinoma cells.
    Sebens Müerköster S; Werbing V; Sipos B; Debus MA; Witt M; Grossmann M; Leisner D; Kötteritzsch J; Kappes H; Klöppel G; Altevogt P; Fölsch UR; Schäfer H
    Oncogene; 2007 Apr; 26(19):2759-68. PubMed ID: 17086212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide, a double edged sword in cancer biology: searching for therapeutic opportunities.
    Mocellin S; Bronte V; Nitti D
    Med Res Rev; 2007 May; 27(3):317-52. PubMed ID: 16991100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide releasing nanomaterials for cancer treatment: current status and perspectives.
    Seabra AB; de Lima R; Calderón M
    Curr Top Med Chem; 2015; 15(4):298-308. PubMed ID: 25579351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inducible nitric oxide synthase enhances disease aggressiveness in pancreatic cancer.
    Wang J; He P; Gaida M; Yang S; Schetter AJ; Gaedcke J; Ghadimi BM; Ried T; Yfantis H; Lee D; Weiss JM; Stauffer J; Hanna N; Alexander HR; Hussain SP
    Oncotarget; 2016 Aug; 7(33):52993-53004. PubMed ID: 27367029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NO
    Wang J; Hussain SP
    Antioxid Redox Signal; 2017 Jun; 26(17):1000-1008. PubMed ID: 27510096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia-activated prodrugs in the treatment of advanced pancreatic adenocarcinoma.
    Babiker HM; Riaz IB; Shah SR; Von Hoff DD; Borad MJ
    Anticancer Drugs; 2017 Feb; 28(2):127-132. PubMed ID: 27685167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the sphingomyelin content of isolated pancreatic islets. Evaluation of the role of sphingomyelin hydrolysis in the action of interleukin-1 to induce islet overproduction of nitric oxide.
    Kwon G; Bohrer A; Han X; Corbett JA; Ma Z; Gross RW; McDaniel ML; Turk J
    Biochim Biophys Acta; 1996 Mar; 1300(1):63-72. PubMed ID: 8608164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary hypertension, nitric oxide and nitric oxide-releasing compounds.
    Hagan G; Pepke-Zaba J
    Expert Rev Respir Med; 2011 Apr; 5(2):163-71. PubMed ID: 21510727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The critical roles of activated stellate cells-mediated paracrine signaling, metabolism and onco-immunology in pancreatic ductal adenocarcinoma.
    Fu Y; Liu S; Zeng S; Shen H
    Mol Cancer; 2018 Feb; 17(1):62. PubMed ID: 29458370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory cytokines in human pancreatic cancer.
    Roshani R; McCarthy F; Hagemann T
    Cancer Lett; 2014 Apr; 345(2):157-63. PubMed ID: 23879960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applications for nitric oxide in halting proliferation of tumor cells.
    Reynolds MM; Witzeling SD; Damodaran VB; Medeiros TN; Knodle RD; Edwards MA; Lookian PP; Brown MA
    Biochem Biophys Res Commun; 2013 Feb; 431(4):647-51. PubMed ID: 23337501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Advance in the biology of pancreatic of cancer].
    Buscail L; Bournet B; Dufresne M; Torrisani J; Cordelier P
    Bull Cancer; 2015 Jun; 102(6 Suppl 1):S53-61. PubMed ID: 26118878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide donors: novel cancer therapeutics (review).
    Huerta S; Chilka S; Bonavida B
    Int J Oncol; 2008 Nov; 33(5):909-27. PubMed ID: 18949354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic pancreatitis: a path to pancreatic cancer.
    Pinho AV; Chantrill L; Rooman I
    Cancer Lett; 2014 Apr; 345(2):203-9. PubMed ID: 23981573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric Oxide. V. therapeutic potential of nitric oxide donors and inhibitors.
    Muscará MN; Wallace JL
    Am J Physiol; 1999 Jun; 276(6):G1313-6. PubMed ID: 10362633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide donors for prostate and bladder cancers: Current state and challenges.
    Seabra AB; Durán N
    Eur J Pharmacol; 2018 May; 826():158-168. PubMed ID: 29501865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.